Results: 1-25 | 26-33
Results: 1-25/33

Authors: Stefanadis, C Manolis, A Dernellis, J Tsioufis, C Tsiamis, E Gavras, I Gavras, H Toutouzas, P
Citation: C. Stefanadis et al., Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction, J HUM HYPER, 15(9), 2001, pp. 635-642

Authors: Gavras, I Gavras, H
Citation: I. Gavras et H. Gavras, Role of alpha(2)-adrenergic receptors in hypertension, AM J HYPERT, 14(6), 2001, pp. 171S-177S

Authors: Sugiyama, F Churchill, GA Higgins, DC Johns, C Makaritsis, KP Gavras, H Paigen, B
Citation: F. Sugiyama et al., Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci, GENOMICS, 71(1), 2001, pp. 70-77

Authors: Kintsurashvili, E Duka, I Gavras, I Johns, C Farmakiotis, D Gavras, H
Citation: E. Kintsurashvili et al., Effects of ANG II on bradykinin receptor gene expression in cardiomyocytesand vascular smooth muscle cells, AM J P-HEAR, 281(4), 2001, pp. H1778-H1783

Authors: Gavras, I Manolis, AJ Gavras, H
Citation: I. Gavras et al., The alpha(2)-adrenergic receptors in hypertension and heart failure: experimental and clinical studies, J HYPERTENS, 19(12), 2001, pp. 2115-2124

Authors: Kintsurashvili, E Gavras, I Johns, C Gavras, H
Citation: E. Kintsurashvili et al., Effects of antisense oligodeoxynucleotide targeting of the alpha(2B)-adrenergic receptor messenger RNA in the central nervous system, HYPERTENSIO, 38(5), 2001, pp. 1075-1080

Authors: Gavras, H Brunner, HR
Citation: H. Gavras et Hr. Brunner, Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure, HYPERTENSIO, 37(2), 2001, pp. 342-345

Authors: DeStefano, AL Gavras, H Heard-Costa, N Bursztyn, M Manolis, A Farrer, LA Baldwin, CT Gavras, I Schwartz, F
Citation: Al. Destefano et al., Maternal component in the familial aggregation of hypertension, CLIN GENET, 60(1), 2001, pp. 13-21

Authors: Duka, I Kintsurashvili, E Gavras, I Johns, C Bresnahan, M Gavras, H
Citation: I. Duka et al., Vasoactive potential of the B-1 bradykinin receptor in normotension and hypertension, CIRCUL RES, 88(3), 2001, pp. 275-281

Authors: Elijovich, F Laffer, CL Amador, E Gavras, H Bresnahan, MR Schiffrin, EL
Citation: F. Elijovich et al., Regulation of plasma endothelin by salt in salt-sensitive hypertension, CIRCULATION, 103(2), 2001, pp. 263-268

Authors: Gavras, I Gavras, H
Citation: I. Gavras et H. Gavras, Angiotensin-converting enzyme inhibitors, CUR CL PRAC, 2001, pp. 315-324

Authors: Zhao, ZH Makaritsis, K Francis, CE Gavras, H Ravid, K
Citation: Zh. Zhao et al., A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice, BBA-MOL BAS, 1500(3), 2000, pp. 280-290

Authors: Gavras, I Gavras, H
Citation: I. Gavras et H. Gavras, The antiarrhythmic potential of angiotensin II antagonism: Experience withlosartan, AM J HYPERT, 13(5), 2000, pp. 512-517

Authors: Gavras, H
Citation: H. Gavras, Update on the clinical pharmacology of candesartan cilexetil, AM J HYPERT, 13(1), 2000, pp. 25S-30S

Authors: Duka, I Gavras, I Johns, C Handy, DE Gavras, H
Citation: I. Duka et al., Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction, GEN PH-VASC, 34(2), 2000, pp. 101-106

Authors: Levy, D DeStefano, AL Larson, MG O'Donnell, CJ Lifton, RP Gavras, H Cupples, LA Myers, RH
Citation: D. Levy et al., Evidence for a gene influencing blood pressure on chromosome 17 - Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study, HYPERTENSIO, 36(4), 2000, pp. 477-483

Authors: Makaritsis, KP Johns, C Gavras, L Gavras, H
Citation: Kp. Makaritsis et al., Role of alpha-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice, HYPERTENSIO, 35(2), 2000, pp. 609-613

Authors: Nicolaou, M DeStefano, AL Gavras, I Cupples, LA Manolis, AJ Baldwin, CT Gavras, H Farrer, LA
Citation: M. Nicolaou et al., Genetic predisposition to stroke in relatives of hypertensives, STROKE, 31(2), 2000, pp. 487-492

Authors: Gavras, H
Citation: H. Gavras, Effect of ramipril on cardiovascular events in high-risk patients., N ENG J MED, 343(1), 2000, pp. 65-66

Authors: Gavras, H Gavras, I
Citation: H. Gavras et I. Gavras, Commentary: Implications for the pathophysiology of hypertension and heartfailure derived from clinical experience with drugs modifying the renin-angiotensin system, V CH MO CAR, 1, 2000, pp. 187-190

Authors: Gavras, H
Citation: H. Gavras, Historical evolution of angiotensin II receptor blockers: Therapeutic advantages, J AM S NEPH, 10(4), 1999, pp. S255-S257

Authors: Gavras, I Manolis, A Gavras, H
Citation: I. Gavras et al., Genetic epidemiology of essential hypertension, J HUM HYPER, 13(4), 1999, pp. 225-229

Authors: Baldwin, CT Schwartz, F Baima, J Burzstyn, H DeStefano, AL Gavras, I Handy, DE Joost, O Martel, T Manolis, A Nicolaou, M Bresnahan, M Farrer, L Gavras, H
Citation: Ct. Baldwin et al., Identification of a polymorphic glutamic acid stretch in the alpha(2B)-adrenergic receptor and lack of linkage with essential hypertension, AM J HYPERT, 12(9), 1999, pp. 853-857

Authors: Manolis, AJ Tsalopoulos, E Ramos, C Katsaros, K Dalabiras, P Hatzissavas, J Foussas, S Gavras, I Bresnahan, M Gavras, H
Citation: Aj. Manolis et al., Benefits of central sympathetic suppression with clonidine after acute myocardial infarction, ADV THER, 16(6), 1999, pp. 272-282

Authors: Gavras, I Gavras, H
Citation: I. Gavras et H. Gavras, Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: Results from a 26-week, double-blind, multicentre study, CURR MED R, 15(1), 1999, pp. 15-24
Risultati: 1-25 | 26-33